1. Issue Highlights Clinical Gastroenterology and Hepatology
Ashwin N. Ananthakrishnan, MD, MPH 
Clinical Gastroenterology and Hepatology 
Volume 15, Issue 7, Pages (July 2017)
DOI: /j.cgh
Copyright © 2017 AGA Institute Terms and Conditions

2. Figure 1
Distribution of intervals between (A) mood or anxiety disorder diagnosis and FGID diagnosis and (B) FGID diagnosis and mood or anxiety disorder diagnosis via box plots. Circles represent outlying individuals (above the 95th percentile). A small number of extreme values have been omitted from the figures to preserve graphical resolution. PSY, mood or anxiety disorder diagnosis.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

3. Figure 2
Cumulative sensitivity of EUS-FNA with each FNA pass based on cytology classification 1.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

4. Figure 3
Cumulative sensitivity of EUS-FNA with each FNA pass in mass lesions ≤2 cm vs >2 cm based on cytology classification 1.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

5. Figure 4
Cumulative sensitivity of EUS-FNA with each FNA pass based on the presence or absence of OCE.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

6. Figure 5
Mean VAS pain at baseline (days –5 to –1) and during study treatment (days 1–49) for THC and placebo in patients with chronic abdominal pain (n = 50), subdivided into CP (n = 23) and PSP (n = 27). VASpain scores are shown until day 49, which is the last day of diary for most patients. Gray bars represent baseline period.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions